Select Page

Vivanza Biosciences Share Price History and Return 2012 to 2024

Vivanza Biosciences Limited

Company LogoPrice: ₹3.26
52 Week Low: ₹3.00
52 Week High: ₹11.30
Market Capital: 2.8 Crore (Smallcap)
->
Show Table of Contents

Vivanza Biosciences Stock Highlights

As of 26 Dec 2024, Vivanza Biosciences Stock price is ₹3.26 which is ₹8.04 below 52-week high of ₹11.30 and ₹0.26 above 52-week low of ₹3.00

52-Week High Low

  • Vivanza Biosciences 52-Week High is ₹11.30 occurred on 01 Jan 2024
  • Vivanza Biosciences 52-Week Low is ₹3.00 occurred on 26 Dec 2024

All Time High

  • The all-time high or the highest price that Vivanza Biosciences stocks have ever touched was ₹199.50 and this occurred on 01 Nov 2021.
  • The highest closing price at which Vivanza Biosciences stocks have ever closed was ₹199.00 recorded on 01 Nov 2021.

Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!

Join our WhatsApp group

Join our Telegram group

Your phone number will be HIDDEN to other users.

Vivanza Biosciences Recent Performance

Over the past 15 trading days, the value of Vivanza Biosciences's stock has decreased by ₹0.28 (-7.91%). On 05 Dec 2024, its one share was worth ₹3.54 and by 26 Dec 2024, the value dropped to ₹3.26. During this period it created a highest high of ₹4.01 and lowest low of ₹3.00.

Click on legend items to show/hide respective price lines

Vivanza Biosciences Stock Price Chart From 2012 to 2024

Click on legend items to show/hide respective price lines

Vivanza Biosciences Stock Price History Table From 2012 to 2024

YearVivanza BiosciencesYOY Chg%↑High - ↓Low
2024₹3.26-69.8%

↑ ₹4.03

↓ ₹3.00

2023₹10.77-94.5%

↑ ₹19.75

↓ ₹7.17

2022₹195.003.4%

↑ ₹195.00

↓ ₹152.00

2021₹188.5568.0%

↑ ₹199.00

↓ ₹63.35

2020₹112.20731.1%

↑ ₹114.00

↓ ₹12.45

2019₹13.50-44.4%

↑ ₹24.25

↓ ₹13.50

2018₹24.25-62.6%

↑ ₹78.70

↓ ₹24.25

2017₹64.80-53.8%

↑ ₹191.00

↓ ₹64.80

2016₹140.15123.5%

↑ ₹145.00

↓ ₹45.00

2015₹62.701,154.0%

↑ ₹62.70

↓ ₹4.75

2014₹5.00-81.7%

↑ ₹27.20

↓ ₹4.34

2013₹27.20-14.1%

↑ ₹31.65

↓ ₹27.20

2012₹31.65-

↑ ₹50.00

↓ ₹31.65

Analyzing the Impact of Investing in Vivanza Biosciences

Vivanza Biosciences Stock price in the year 2012 was ₹31.65. If you had invested ₹10,000 in Vivanza Biosciences Stock in 2012, in 12 years, your investment would have reduced to ₹1,030 by the end of 2024. This represents a negative return of -89.7% from 2012 to 2024, with a compound annual growth rate (CAGR) of -17.3%.

Vivanza Biosciences Stock Returns In Last 5 Years

  • Its highest stock price in the last 5 years was: ₹199.50 and lowest was: ₹3.00
  • Vivanza Biosciences Stock price in 2019 was ₹13.50
  • By 2024, its stock price dropped to ₹3.26
  • It gave a negative return of over -75.9% with a CAGR of -24.7% over the last 5 years
  • If you had invested ₹10,000 in Vivanza Biosciences in 2019 then in 5 years, your investment would have declined to ₹2,414.81 by 2024.

Vivanza Biosciences Stock Returns In Last 10 Years

  • Its highest stock price in the last 10 years was: ₹199.50 and lowest was: ₹3.00
  • Vivanza Biosciences Stock price in 2014 was ₹5.00
  • By 2024, its stock price dropped to ₹3.26
  • It gave a negative return of over -34.8% with a CAGR of -4.2% over the last 10 years
  • If you had invested ₹10,000 in Vivanza Biosciences in 2014 then in 10 years, your investment would have declined to ₹6,520 by 2024.

Vivanza Biosciences Returns vs Bank FD Returns

Investment TypeInitial AmountFinal ValueTotal Returns
Vivanza Biosciences Shares₹10,000₹1,030.01-89.7%
Bank FD (Simple Interest)₹10,000₹17,20072.0%
Bank FD (Compound Interest)₹10,000₹20,121.96101.2%

Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.

All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.